Skip to main content
Genmab logo

Genmab — Investor Relations & Filings

Ticker · GMAB ISIN · DK0010272202 LEI · 529900MTJPDPE4MHJ122 CO Manufacturing
Open in API
Filings indexed 2,819 across all filing types
Latest filing 2022-12-13 Share Issue/Capital Cha…
Country DK Denmark
Listing CO GMAB

About Genmab

https://www.genmab.com/

Genmab is an international biotechnology company that specializes in the creation, development, and commercialization of differentiated antibody therapeutics. The company focuses on transforming the treatment of cancer and other serious diseases. By utilizing proprietary antibody technology platforms and scientific expertise, Genmab develops a pipeline of innovative medicines. Its activities span from discovery and research through clinical development to deliver novel therapies to patients.

Recent filings

Filing Released Lang Actions
Capital Increase in Genmab as a Result of Employee Warrant Exercise
Share Issue/Capital Change Classification · 1% confidence The document is a company announcement regarding a capital increase resulting from the exercise of employee warrants. It details the number of shares issued, the subscription prices, and the resulting change in total share capital. This falls under the category of share issues or capital changes. While it mentions an attachment, the text itself provides the full details of the transaction, making it a primary announcement of a capital change rather than just a notification of a report publication.
2022-12-13 Danish
6-K
Foreign Filer Report
2022-11-29 English
6-K
Foreign Filer Report
2022-11-23 English
Director's Dealing 2022
Director's Dealing Classification · 1% confidence The document explicitly details 'Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons.' It lists a specific transaction (Sale of Shares) by an executive (Judith Klimovsky) on a specific date (2022-11-22), referencing regulatory requirements (Article 19 of Regulation No. 596/2014). This content directly corresponds to the definition of Director's Dealing (insider trades by executives/directors).
2022-11-23 English
Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons
Director's Dealing Classification · 1% confidence The document is a company announcement regarding transactions in shares by managerial employees and their closely associated persons. It explicitly references Article 19 of Regulation No. 596/2014 (Market Abuse Regulation), which governs insider trading disclosures. While the document mentions an attachment, the text itself serves as the official notification of these director/managerial dealings. Therefore, it is classified as a Director's Dealing (DIRS).
2022-11-23 Danish
6-K
Foreign Filer Report
2022-11-21 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.